Home

Addressing critical unmet needs in bleeding management

Trauma

Emergency stabilization of hemorrhage improves patient survival following trauma

Hospital

Cost-effective therapy that supports reactive OR proactive treatment for surgical bleeding

Healing

Unique mechanism of action supports and improves overall wound healing outcomes after cessation of bleeding

Safety

Wound-targeting technology minimizes risk of immune or thrombotic complications

Supply Chain

Fast scale-up and easy storage & transport to address critical platelet shortages

REVOLUTIONIZING HEMORRHAGE CONTROL

SymClot: A Novel Therapy to Control Bleeding

SelSym Biotech’s lead product, SymClot,¬†mimics platelet functions to augment hemorrhage control in trauma and surgery and helps to¬†address critical ongoing platelet supply shortages and shelf life limitations

PLATFORM TECHNOLOGY

Hemostatic Healing Hydrogels (H3)

SelSym Biotech’s suite of Hemostatic Healing Hydrogels (H3) can be easily tuned to address a wide range of clinical needs in bleeding management and wound healing, including hemorrhage control, drug delivery, infection control, and long-term healing support for chronic wounds

Interested in partnering with us?

Contact